Avara Pharmaceutical Services Expands to Facility in Boucherville, Quebec
05/27/2018
According to company officials, “the proposed acquisition of Novartis Technical Operations' sterile manufacturing facility and the adjacent Sandoz Development Center located on the Sandoz Canada campus in Boucherville, Quebec, is expected to be finalized in the next few months, following the completion of a number of closing conditions including receipt of anti-trust approvals.”
"This acquisition represents our first entry into the Canadian market and further expands our sterile processing capability, which is in very high demand," said Timothy C. Tyson, Avara's Chairman & CEO. "It comes with a world-class development center and a dedicated team of experts that will support us in delivering high-quality pharmaceuticals that meet or exceed customer expectations and regulatory requirements."
The Boucherville site is the biggest injectables production facility in Canada and provides a number of strategic and lifesaving medicines to the Canadian healthcare system, mostly hospitals.
As part of the asset purchase agreement, the parties have committed to sign a long-term supply contract to guarantee continuous supply of products manufactured in Boucherville. No impact on jobs is anticipated at the moment and Avara intends to invest in the site and pursue business development opportunities to optimize the plant's utilization and expand its customer base.
"We look forward to a seamless transition for employees, patients, customers, partners and other stakeholders," added Mr. Tyson. "We are impressed by the know-how at the Boucherville plant and Sandoz Development Center team and intend to leverage their expertise to develop new opportunities in the contract pharmaceutical market, in Canada and elsewhere."
The latest agreement follows Avara's acquisition of another sterile facility in the past year, one from Pfizer Inc. in Liscate, Italy, and one solid dose manufacturing facility from GlaxoSmithKline in Aiken, South Carolina. It will bring the number of manufacturing and development sites operated by Avara worldwide to ten: two in Canada; three in the United States, including corporate headquarters; one in Puerto Rico; one in the United Kingdom; one in Ireland; one in Italy; and one in France.
Project Announcements
AeroVironment Plans Salt Lake City, Utah, Manufacturing Operations
02/15/2025
Amazon Plans Salina, Kansas, Distribution Operations
02/15/2025
Loukus Technologies Expands Calumet, Michigan, Operations
02/15/2025
Great Lakes Sound & Vibration Expands Franklin Township, Michigan, Operations
02/15/2025
Taiwan-Based Syntec Precision Technology Plans Henderson, North Carolina, Operations
02/15/2025
Key Tronic Plans Springdale, Arkansas, Manufacturing-R&D Operations
02/15/2025
Most Read
-
2024's Leading Metro Locations: U.S. Cities on the Rise Amid an Economic Reshuffling
Q4 2024
-
The Workforce Factor: How States Are Competing to Build Tomorrow's Talent
Q4 2024
-
Best Practices in Incentives Procurement
Q4 2024
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Five Strategies to Tackle the Data Center Talent Shortage
Q4 2024
-
Microsoft-Three Mile Island Deal Could Signal Path for Nuclear Power to Strengthen Partnerships with Big Tech
Q4 2024
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024